100 related articles for article (PubMed ID: 1492229)
1. Role of etoposide in treatment of breast cancer.
Nichols CR
Semin Oncol; 1992 Dec; 19(6 Suppl 13):67-71. PubMed ID: 1492229
[TBL] [Abstract][Full Text] [Related]
2. Etoposide in the management of metastatic breast cancer.
Sledge GW
Cancer; 1991 Jan; 67(1 Suppl):266-70. PubMed ID: 1984826
[TBL] [Abstract][Full Text] [Related]
3. Etoposide in gastric cancer.
Macdonald JS; Havlin KA
Semin Oncol; 1992 Dec; 19(6 Suppl 13):59-62. PubMed ID: 1492227
[TBL] [Abstract][Full Text] [Related]
4. Platinum compounds in the treatment of advanced breast cancer.
Martín M
Clin Breast Cancer; 2001 Oct; 2(3):190-208; discussion 209. PubMed ID: 11899413
[TBL] [Abstract][Full Text] [Related]
5. Long-term oral etoposide in metastatic breast cancer: clinical and pharmacokinetic results.
Calvert AH; Lind MJ; Millward MM; Cantwell BM; Gumbrell L; Proctor M; Simmons D; Chapman F; Robinson A; Charlton C
Cancer Treat Rev; 1993; 19 Suppl C():27-33. PubMed ID: 8221713
[TBL] [Abstract][Full Text] [Related]
6. Etoposide: a semisynthetic epipodophyllotoxin. Chemistry, pharmacology, pharmacokinetics, adverse effects and use as an antineoplastic agent.
Sinkule JA
Pharmacotherapy; 1984; 4(2):61-73. PubMed ID: 6326063
[TBL] [Abstract][Full Text] [Related]
7. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
8. Platinum-based chemotherapy in metastatic breast cancer: current status.
Decatris MP; Sundar S; O'Byrne KJ
Cancer Treat Rev; 2004 Feb; 30(1):53-81. PubMed ID: 14766126
[TBL] [Abstract][Full Text] [Related]
9. Ifosfamide, carboplatin, etoposide, and paclitaxel chemotherapy: a dose-escalation study.
Chang AY; Boros L; Garrow GC; Asbury RF; Hui L
Semin Oncol; 1996 Jun; 23(3 Suppl 6):74-7. PubMed ID: 8677454
[TBL] [Abstract][Full Text] [Related]
10. Phase II trial of cisplatin and etoposide as first-line therapy in metastatic breast carcinoma.
Lluch A; Azagra P; Cervantes A; Muñoz M; Alberola V; Santabarbara P; García-Conde J
Oncology; 1994; 51(4):352-5. PubMed ID: 8208520
[TBL] [Abstract][Full Text] [Related]
11. Adjuvant oral etoposide plus cisplatin (EoP) following sequential doxorubicin/cyclophosphamide (AC) and docetaxel (T) in early breast cancer patients with 4 or more positive lymph nodes (10 years follow-up).
Icli F; Akbulut H; Onur H; Yalcin B; Demirkazık A; Senler FÇ
Breast; 2011 Apr; 20(2):155-7. PubMed ID: 20951586
[TBL] [Abstract][Full Text] [Related]
12. Prolonged administration of oral etoposide plus cisplatin in extensive stage small cell lung cancer.
Greco FA; Murphy PB; Hainsworth JD; Hande KR; Johnson DH
Oncology; 1992; 49 Suppl 1():34-8; discussion 39. PubMed ID: 1323810
[TBL] [Abstract][Full Text] [Related]
13. Combined chemotherapy with cisplatin, etoposide, and irinotecan versus topotecan alone as second-line treatment for patients with sensitive relapsed small-cell lung cancer (JCOG0605): a multicentre, open-label, randomised phase 3 trial.
Goto K; Ohe Y; Shibata T; Seto T; Takahashi T; Nakagawa K; Tanaka H; Takeda K; Nishio M; Mori K; Satouchi M; Hida T; Yoshimura N; Kozuki T; Imamura F; Kiura K; Okamoto H; Sawa T; Tamura T;
Lancet Oncol; 2016 Aug; 17(8):1147-1157. PubMed ID: 27312053
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin Plus Ifosfamide with/without Etoposide as Salvage Treatment in Heavily-pre-treated Patients with Metastatic Breast Cancer.
Habbel P; Kurreck A; Schulz CO; Regierer AC; Kaul D; Scholz CW; Neumann C; Possinger K; Eucker J
Anticancer Res; 2015 Sep; 35(9):5091-5. PubMed ID: 26254412
[TBL] [Abstract][Full Text] [Related]
15. Etoposide in the treatment of leukemias.
Bishop JF
Semin Oncol; 1992 Dec; 19(6 Suppl 13):33-8. PubMed ID: 1492226
[TBL] [Abstract][Full Text] [Related]
16. Docetaxel in combination chemotherapy for metastatic breast cancer.
Khayat D; Antoine E
Semin Oncol; 1997 Aug; 24(4 Suppl 13):S13-19-S13-26. PubMed ID: 9335513
[TBL] [Abstract][Full Text] [Related]
17. Exploring the use of chronic low-dose oral etoposide in ovarian cancer: is there a role for this "new drug" in the management of platinum-refractory disease?
Markman M; Hakes T; Reichman B; Barakat R; Curtin J; Jones W; Lewis JL; Rubin S; Almadrones L; Hoskins W
Semin Oncol; 1992 Dec; 19(6 Suppl 14):25-7. PubMed ID: 1488652
[TBL] [Abstract][Full Text] [Related]
18. Cisplatin and platinum analogues in breast cancer.
Sledge GW
Semin Oncol; 1992 Feb; 19(1 Suppl 2):78-82. PubMed ID: 1411630
[TBL] [Abstract][Full Text] [Related]
19. Two novel high-dose treatment regimens for metastatic breast cancer--ifosfamide, carboplatin, plus etoposide and mitoxantrone plus thiotepa: outcomes and toxicities.
Fields KK; Elfenbein GJ; Perkins JB; Hiemenz JW; Janssen WE; Zorsky PE; Ballester OF; Kronish LE; Foody MC
Semin Oncol; 1993 Oct; 20(5 Suppl 6):59-66. PubMed ID: 8211217
[TBL] [Abstract][Full Text] [Related]
20. Docetaxel (Taxotere) in combination: a step forward.
Burris HA; Fields S; Peacock N
Semin Oncol; 1995 Dec; 22(6 Suppl 13):35-40. PubMed ID: 8604452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
